Article
Neuroimaging Biomarkers in Parkinson's Disease: Current Applications and Future Directions
2026-08-19
Abstract excerpt
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by α-synuclein (αSyn) aggregation, dopaminergic neuronal loss within the substantia nigra (SN), and widespread involvement of multiple neurotransmitter systems. The recognition of prodromal and preclinical disease stages has accelerated efforts to develop biomarkers capable of identifying underlying pathology before the onset of mot...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- afda156a-6348-5adf-a76f-738fdab381a6
- DOI
- 10.20944/preprints202608.1342.v1
